According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

Opens in a new tab or window The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ...

The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

a director for the FDA’s Center for Drug Evaluation and Research. Start the day smarter. Get all the news you need in your inbox each morning. Neffy is a single-dose nasal spray approved by ...

According to the FDA, the epinephrine nasal spray bears similar side effects to injectable allergy medications like EpiPen, such as jitters and heart palpitations. However, side effects specific ...

The Food and Drug Administration approved Friday a nasal spray for serious ... injections," Kelly Stone, FDA's associate director of the Division of Pulmonology, Allergy and Critical Care, said ...

allergy, and critical care in the FDA’s Center for Drug Evaluation and Research, in a statement. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...

a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...

U.S. health officials on Friday approved a nasal spray to treat severe ... She said, “we are over the moon” about the FDA’s approval of the spray, which Zacky will start carrying when ...